Study Design: Prospective nonrandomized clinical series.
Objectives: To evaluate the efficacy of ProDisc lumbar artificial disc replacement (ADR) in smokers versus nonsmokers.
Summary Of Background Data: Smoking is a negative predictor in fusion surgery.
Object: The authors conducted a prospective longitudinal study to obtain outcome (minimum follow-up period 2 years) regarding the safety and efficacy of single-level lumbar disc (ProDisc prosthesis) replacement in patients 60 years of age or older.
Methods: This prospective analysis involved 22 patients treated in whom the lumbar ProDisc prosthesis was used for total disc arthroplasty. All patients presented with disabling discogenic low-back pain (LBP) with or without radicular pain.
Study Design: Prospective, longitudinal minimum 2-year follow-up.
Objective: To assess the efficacy and safety of the Prodisc implant in patients with disabling single-level discogenic low back pain (LBP).
Summary Of Background Data: The treatment of debilitating discogenic LBP has been controversial and varied.
Study Design: Prospective, longitudinal minimum 2-year follow-up.
Objective: To assess the efficacy and safety of the Prodisc implant in patients with disabling multilevel discogenic low back pain (LBP).
Summary Of Background Data: Few, if any, alternatives have been proposed to treat recalcitrant and debilitating multilevel lumbar discogenic low back pain.
Object: Cervical anterior decompression and total-disc replacement is currently being investigated as an alternative treatment in patients with symptomatic intervertebral cervical spondylosis with and without radiculopathy. The authors prospectively investigated the safety and efficacy of using the ProDisc-C disc for cervical arthroplasty in the treatment of symptomatic cervical spondylosis.
Methods: Sixteen patients in whom a diagnosis of symptomatic cervical spondylosis had been established were prospectively treated with complete anterior cervical discectomy and ProDisc-C cervical disc arthroplasty.